Concepts (332)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bibliometrics | 11 | 2021 | 339 | 3.160 |
Why?
|
Analgesics | 16 | 2023 | 1037 | 3.090 |
Why?
|
Anesthetics | 22 | 2021 | 538 | 2.880 |
Why?
|
Analgesia | 17 | 2023 | 459 | 2.540 |
Why?
|
Diterpenes | 9 | 2011 | 173 | 2.260 |
Why?
|
Anesthetics, General | 4 | 2023 | 152 | 2.200 |
Why?
|
Nerve Block | 15 | 2017 | 640 | 1.870 |
Why?
|
Pain, Postoperative | 19 | 2017 | 1638 | 1.810 |
Why?
|
Alfentanil | 13 | 2001 | 27 | 1.690 |
Why?
|
Midazolam | 18 | 1997 | 270 | 1.480 |
Why?
|
Thiopental | 16 | 1999 | 59 | 1.410 |
Why?
|
Drug Discovery | 6 | 2019 | 1057 | 1.370 |
Why?
|
Anesthesiology | 5 | 2021 | 1043 | 1.350 |
Why?
|
Morphine | 23 | 2009 | 657 | 1.330 |
Why?
|
Hyperalgesia | 11 | 2008 | 502 | 1.330 |
Why?
|
Anesthesia, General | 10 | 2023 | 1164 | 1.280 |
Why?
|
Anesthesia | 13 | 2021 | 1548 | 1.280 |
Why?
|
Pain | 23 | 2015 | 4961 | 1.260 |
Why?
|
Anesthetics, Local | 8 | 2016 | 984 | 1.160 |
Why?
|
Periodicals as Topic | 5 | 2021 | 1431 | 1.140 |
Why?
|
Peripheral Nerves | 7 | 2017 | 474 | 1.060 |
Why?
|
Anesthesia, Local | 4 | 2017 | 268 | 0.940 |
Why?
|
History, 21st Century | 9 | 2021 | 1533 | 0.900 |
Why?
|
Isoflurane | 5 | 2023 | 381 | 0.870 |
Why?
|
TRPV Cation Channels | 5 | 2011 | 235 | 0.830 |
Why?
|
Neuralgia | 3 | 2022 | 568 | 0.820 |
Why?
|
History, 20th Century | 10 | 2021 | 2739 | 0.800 |
Why?
|
Lidocaine | 9 | 2016 | 542 | 0.790 |
Why?
|
Scientific Misconduct | 1 | 2022 | 71 | 0.780 |
Why?
|
Bupivacaine | 8 | 2016 | 408 | 0.750 |
Why?
|
Drug Tolerance | 13 | 2009 | 375 | 0.750 |
Why?
|
Publications | 2 | 2021 | 195 | 0.750 |
Why?
|
Fentanyl | 12 | 1998 | 410 | 0.730 |
Why?
|
Biomedical Research | 4 | 2021 | 3306 | 0.730 |
Why?
|
Analgesics, Opioid | 13 | 2023 | 3667 | 0.700 |
Why?
|
Drug Industry | 2 | 2016 | 744 | 0.690 |
Why?
|
Anesthesia, Intravenous | 9 | 1994 | 130 | 0.690 |
Why?
|
Authorship | 1 | 2022 | 271 | 0.660 |
Why?
|
Sciatic Nerve | 7 | 2007 | 609 | 0.660 |
Why?
|
Halothane | 14 | 1989 | 206 | 0.640 |
Why?
|
Drug Interactions | 25 | 2023 | 1458 | 0.640 |
Why?
|
Anesthetics, Inhalation | 1 | 2023 | 571 | 0.610 |
Why?
|
PubMed | 1 | 2018 | 122 | 0.600 |
Why?
|
Patents as Topic | 1 | 2018 | 103 | 0.580 |
Why?
|
Dose-Response Relationship, Drug | 42 | 2023 | 10943 | 0.550 |
Why?
|
Hypnotics and Sedatives | 9 | 1999 | 1158 | 0.520 |
Why?
|
Rats | 55 | 2008 | 24265 | 0.510 |
Why?
|
Drug Therapy | 1 | 2017 | 497 | 0.480 |
Why?
|
Capsaicin | 4 | 2011 | 229 | 0.460 |
Why?
|
Autonomic Nerve Block | 2 | 2011 | 72 | 0.450 |
Why?
|
Neurology | 2 | 2019 | 762 | 0.450 |
Why?
|
United States Food and Drug Administration | 2 | 2018 | 1581 | 0.430 |
Why?
|
Clinical Trials as Topic | 4 | 2021 | 7901 | 0.430 |
Why?
|
Rats, Sprague-Dawley | 20 | 2008 | 8300 | 0.420 |
Why?
|
Anesthesia, Spinal | 4 | 2016 | 269 | 0.400 |
Why?
|
Neurotransmitter Agents | 1 | 2015 | 647 | 0.400 |
Why?
|
Ketamine | 5 | 2000 | 499 | 0.380 |
Why?
|
Anesthetics, Intravenous | 3 | 1999 | 417 | 0.380 |
Why?
|
Choice Behavior | 1 | 2016 | 802 | 0.370 |
Why?
|
Pain Measurement | 9 | 2009 | 3418 | 0.360 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2018 | 1372 | 0.360 |
Why?
|
Career Choice | 1 | 2016 | 743 | 0.360 |
Why?
|
Pentobarbital | 7 | 1993 | 155 | 0.360 |
Why?
|
Rats, Inbred Strains | 26 | 1991 | 2191 | 0.360 |
Why?
|
Drug Approval | 1 | 2016 | 740 | 0.340 |
Why?
|
Pain Threshold | 8 | 2015 | 585 | 0.330 |
Why?
|
Analgesia, Patient-Controlled | 1 | 2009 | 109 | 0.330 |
Why?
|
Sciatica | 4 | 1990 | 98 | 0.330 |
Why?
|
Monitoring, Intraoperative | 1 | 2015 | 953 | 0.320 |
Why?
|
Myelitis | 1 | 2008 | 53 | 0.310 |
Why?
|
Anesthetics, Combined | 2 | 1997 | 40 | 0.310 |
Why?
|
Animals | 77 | 2021 | 168561 | 0.300 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2007 | 99 | 0.300 |
Why?
|
Psychiatry | 1 | 2019 | 1695 | 0.290 |
Why?
|
Sodium Channel Blockers | 2 | 2023 | 176 | 0.290 |
Why?
|
Sciatic Neuropathy | 1 | 2007 | 74 | 0.290 |
Why?
|
Calcium Channel Blockers | 4 | 2008 | 689 | 0.290 |
Why?
|
Neural Conduction | 1 | 2008 | 468 | 0.290 |
Why?
|
Drug Design | 3 | 2018 | 1078 | 0.280 |
Why?
|
Carrageenan | 4 | 2008 | 66 | 0.260 |
Why?
|
Unconsciousness | 3 | 2000 | 262 | 0.250 |
Why?
|
Nerve Fibers | 1 | 2008 | 688 | 0.250 |
Why?
|
Pharmaceutical Preparations | 1 | 2013 | 1071 | 0.240 |
Why?
|
Diazepam | 6 | 1990 | 205 | 0.240 |
Why?
|
Calcium Channels, L-Type | 1 | 2005 | 238 | 0.240 |
Why?
|
Anesthesia, Epidural | 2 | 2016 | 227 | 0.230 |
Why?
|
Microscopy, Electron | 1 | 2007 | 2645 | 0.230 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2723 | 0.230 |
Why?
|
Adrenergic Agonists | 1 | 2023 | 58 | 0.230 |
Why?
|
Saphenous Vein | 1 | 2006 | 531 | 0.230 |
Why?
|
Arthritis, Experimental | 1 | 2005 | 291 | 0.220 |
Why?
|
Analgesia, Epidural | 2 | 2005 | 326 | 0.220 |
Why?
|
Drug Synergism | 13 | 1999 | 1791 | 0.210 |
Why?
|
Clonidine | 1 | 2003 | 164 | 0.210 |
Why?
|
Humans | 75 | 2022 | 742088 | 0.200 |
Why?
|
Time Factors | 12 | 2021 | 40054 | 0.190 |
Why?
|
Inflammation | 4 | 2008 | 10578 | 0.180 |
Why?
|
Propofol | 2 | 1999 | 628 | 0.180 |
Why?
|
Cholecystokinin | 1 | 2000 | 114 | 0.180 |
Why?
|
History, 19th Century | 2 | 2021 | 720 | 0.180 |
Why?
|
Heart Rate | 12 | 1986 | 4091 | 0.180 |
Why?
|
Reflex | 10 | 1993 | 365 | 0.170 |
Why?
|
Tonsillectomy | 2 | 1993 | 254 | 0.170 |
Why?
|
Protein Kinase C | 2 | 2008 | 1227 | 0.170 |
Why?
|
Spinal Cord | 2 | 2023 | 1807 | 0.170 |
Why?
|
Receptors, Opioid | 4 | 1996 | 155 | 0.160 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2000 | 449 | 0.160 |
Why?
|
Myocardial Contraction | 8 | 1984 | 1585 | 0.160 |
Why?
|
Hindlimb | 1 | 1999 | 505 | 0.150 |
Why?
|
Injections, Intravenous | 8 | 1998 | 1420 | 0.150 |
Why?
|
Journal Impact Factor | 1 | 2018 | 156 | 0.150 |
Why?
|
Memory | 1 | 2006 | 2163 | 0.140 |
Why?
|
Double-Blind Method | 13 | 1998 | 12017 | 0.140 |
Why?
|
Infusions, Intravenous | 5 | 2000 | 2271 | 0.140 |
Why?
|
Nociceptors | 3 | 1991 | 432 | 0.140 |
Why?
|
Male | 68 | 2008 | 349538 | 0.130 |
Why?
|
Organizations | 1 | 2016 | 170 | 0.130 |
Why?
|
Meperidine | 1 | 1995 | 38 | 0.130 |
Why?
|
Gene Expression | 1 | 2008 | 7790 | 0.130 |
Why?
|
Structure-Activity Relationship | 2 | 2011 | 3133 | 0.120 |
Why?
|
Publishing | 1 | 2022 | 833 | 0.120 |
Why?
|
Hypnosis, Anesthetic | 1 | 1993 | 7 | 0.120 |
Why?
|
Research Support as Topic | 1 | 2018 | 704 | 0.120 |
Why?
|
Metoclopramide | 1 | 1993 | 50 | 0.120 |
Why?
|
Premedication | 1 | 1994 | 257 | 0.120 |
Why?
|
Pain Perception | 1 | 2015 | 190 | 0.120 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 725 | 0.110 |
Why?
|
Anesthesia, Conduction | 1 | 2016 | 238 | 0.110 |
Why?
|
Hypnosis | 1 | 1992 | 82 | 0.110 |
Why?
|
Sensory Thresholds | 6 | 1996 | 394 | 0.100 |
Why?
|
Spinal Nerve Roots | 2 | 1989 | 124 | 0.100 |
Why?
|
Motor Activity | 5 | 1992 | 2714 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2276 | 0.100 |
Why?
|
Lipids | 1 | 2023 | 3302 | 0.100 |
Why?
|
Adenoidectomy | 1 | 1993 | 159 | 0.100 |
Why?
|
Methyl Ethers | 2 | 1983 | 205 | 0.100 |
Why?
|
Nitric Oxide | 1 | 2000 | 2128 | 0.100 |
Why?
|
Movement | 6 | 1990 | 1470 | 0.100 |
Why?
|
Pressure | 5 | 1998 | 1203 | 0.100 |
Why?
|
Drug Combinations | 5 | 1999 | 1961 | 0.090 |
Why?
|
Safety | 1 | 2015 | 1185 | 0.090 |
Why?
|
Administration, Cutaneous | 1 | 2012 | 711 | 0.090 |
Why?
|
Piperidines | 1 | 1998 | 1602 | 0.090 |
Why?
|
Postoperative Care | 1 | 1996 | 1484 | 0.090 |
Why?
|
Coronary Disease | 5 | 1989 | 6078 | 0.090 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1483 | 0.080 |
Why?
|
Behavior, Animal | 3 | 1998 | 1882 | 0.080 |
Why?
|
Nifedipine | 4 | 1983 | 226 | 0.080 |
Why?
|
Placebos | 3 | 1998 | 1677 | 0.080 |
Why?
|
Hernia, Inguinal | 1 | 1990 | 202 | 0.080 |
Why?
|
Hot Temperature | 3 | 2007 | 1355 | 0.080 |
Why?
|
Myocardium | 5 | 1983 | 4775 | 0.070 |
Why?
|
Terminology as Topic | 1 | 1994 | 1548 | 0.070 |
Why?
|
Arousal | 1 | 1993 | 1165 | 0.070 |
Why?
|
Herpes Zoster | 1 | 1989 | 264 | 0.070 |
Why?
|
Neurosecretory Systems | 1 | 2008 | 231 | 0.070 |
Why?
|
Enflurane | 2 | 1983 | 17 | 0.070 |
Why?
|
Ligation | 1 | 2007 | 453 | 0.070 |
Why?
|
Research Design | 1 | 2002 | 5979 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2749 | 0.070 |
Why?
|
Reserpine | 1 | 1985 | 66 | 0.070 |
Why?
|
Receptors, GABA-A | 4 | 1993 | 627 | 0.070 |
Why?
|
Touch | 1 | 1987 | 306 | 0.070 |
Why?
|
Molecular Structure | 1 | 2010 | 1907 | 0.070 |
Why?
|
Naloxone | 2 | 1987 | 367 | 0.070 |
Why?
|
Coronary Circulation | 2 | 1989 | 1572 | 0.060 |
Why?
|
Electroencephalography | 1 | 2000 | 6142 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2011 | 62966 | 0.060 |
Why?
|
Peroneal Nerve | 1 | 1984 | 79 | 0.060 |
Why?
|
Calcium Channels | 1 | 2008 | 621 | 0.060 |
Why?
|
Injections, Intra-Articular | 1 | 2005 | 278 | 0.060 |
Why?
|
Neural Pathways | 1 | 2015 | 2971 | 0.060 |
Why?
|
Etomidate | 2 | 1983 | 190 | 0.060 |
Why?
|
Cerebrovascular Disorders | 1 | 1991 | 1499 | 0.060 |
Why?
|
Drug Utilization | 1 | 2010 | 1181 | 0.060 |
Why?
|
Single-Blind Method | 2 | 1998 | 1589 | 0.060 |
Why?
|
Ethyl Ethers | 1 | 1983 | 20 | 0.060 |
Why?
|
Dogs | 8 | 1986 | 3910 | 0.060 |
Why?
|
Students, Medical | 1 | 2016 | 1858 | 0.060 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2005 | 305 | 0.060 |
Why?
|
Physical Stimulation | 2 | 2000 | 525 | 0.060 |
Why?
|
Middle Aged | 23 | 1999 | 213127 | 0.060 |
Why?
|
Nerve Degeneration | 1 | 2007 | 748 | 0.050 |
Why?
|
Iatrogenic Disease | 1 | 2006 | 545 | 0.050 |
Why?
|
Adult | 21 | 1999 | 213712 | 0.050 |
Why?
|
Energy Metabolism | 3 | 1983 | 2896 | 0.050 |
Why?
|
Random Allocation | 3 | 1992 | 2425 | 0.050 |
Why?
|
Postural Balance | 5 | 1985 | 620 | 0.050 |
Why?
|
Posture | 3 | 1992 | 958 | 0.050 |
Why?
|
Coronary Vasospasm | 1 | 1982 | 88 | 0.050 |
Why?
|
Species Specificity | 1 | 2005 | 2479 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 1994 | 2400 | 0.050 |
Why?
|
Proglumide | 1 | 2000 | 3 | 0.050 |
Why?
|
Receptors, Cholecystokinin | 1 | 2000 | 18 | 0.050 |
Why?
|
Benzodiazepinones | 1 | 2000 | 51 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4751 | 0.050 |
Why?
|
Injections, Spinal | 3 | 1998 | 303 | 0.050 |
Why?
|
United States | 3 | 2018 | 69693 | 0.050 |
Why?
|
Dizocilpine Maleate | 1 | 2000 | 176 | 0.050 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2000 | 255 | 0.050 |
Why?
|
Tetracaine | 1 | 1999 | 34 | 0.040 |
Why?
|
Stress, Physiological | 2 | 1987 | 1402 | 0.040 |
Why?
|
Meglumine | 1 | 2000 | 149 | 0.040 |
Why?
|
Skin | 3 | 1997 | 4353 | 0.040 |
Why?
|
N-Methylaspartate | 1 | 2000 | 231 | 0.040 |
Why?
|
Propranolol | 1 | 1981 | 502 | 0.040 |
Why?
|
Anesthesia, Inhalation | 3 | 1993 | 223 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3920 | 0.040 |
Why?
|
Carbon Dioxide | 3 | 1993 | 1141 | 0.040 |
Why?
|
Models, Animal | 1 | 2005 | 2170 | 0.040 |
Why?
|
Central Nervous System | 1 | 2006 | 1354 | 0.040 |
Why?
|
NAD | 4 | 1983 | 594 | 0.040 |
Why?
|
Critical Care | 1 | 1991 | 2640 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 1998 | 379 | 0.040 |
Why?
|
Blinking | 1 | 1998 | 138 | 0.040 |
Why?
|
Biological Assay | 1 | 1980 | 652 | 0.040 |
Why?
|
Imidazoles | 1 | 1983 | 1205 | 0.040 |
Why?
|
Neurons, Afferent | 1 | 1999 | 508 | 0.040 |
Why?
|
Tachyphylaxis | 1 | 1997 | 51 | 0.040 |
Why?
|
Phenylurea Compounds | 1 | 2000 | 526 | 0.040 |
Why?
|
Benzodiazepines | 3 | 1993 | 1101 | 0.040 |
Why?
|
Miotics | 1 | 1996 | 9 | 0.040 |
Why?
|
Knee Joint | 1 | 2005 | 1679 | 0.040 |
Why?
|
Female | 21 | 1999 | 379592 | 0.040 |
Why?
|
Intraoperative Care | 3 | 1993 | 766 | 0.040 |
Why?
|
Pyridines | 3 | 1983 | 2818 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5774 | 0.030 |
Why?
|
Calcium | 2 | 2008 | 5753 | 0.030 |
Why?
|
Hemodynamics | 3 | 1998 | 4197 | 0.030 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 1999 | 349 | 0.030 |
Why?
|
Monitoring, Physiologic | 2 | 2000 | 1737 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 24913 | 0.030 |
Why?
|
Vocalization, Animal | 2 | 1993 | 87 | 0.030 |
Why?
|
Subarachnoid Space | 1 | 1994 | 79 | 0.030 |
Why?
|
Ischemia | 1 | 1984 | 1911 | 0.030 |
Why?
|
Cold Temperature | 1 | 1998 | 774 | 0.030 |
Why?
|
Droperidol | 1 | 1993 | 21 | 0.030 |
Why?
|
Afferent Pathways | 1 | 1994 | 302 | 0.030 |
Why?
|
Barbiturates | 1 | 1993 | 114 | 0.030 |
Why?
|
Partial Pressure | 1 | 1993 | 253 | 0.030 |
Why?
|
Papillary Muscles | 2 | 1984 | 200 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2008 | 13029 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 1998 | 2030 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2009 | 9941 | 0.030 |
Why?
|
Sufentanil | 1 | 1991 | 40 | 0.030 |
Why?
|
Signal Transduction | 1 | 2015 | 23387 | 0.030 |
Why?
|
Adolescent | 6 | 1999 | 85649 | 0.030 |
Why?
|
Indoles | 1 | 2000 | 1834 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9410 | 0.030 |
Why?
|
Rabbits | 3 | 1983 | 4886 | 0.020 |
Why?
|
Morphine Derivatives | 1 | 1991 | 44 | 0.020 |
Why?
|
Palatine Tonsil | 1 | 1991 | 193 | 0.020 |
Why?
|
Opioid-Related Disorders | 1 | 2006 | 2062 | 0.020 |
Why?
|
Sodium Chloride | 1 | 1993 | 625 | 0.020 |
Why?
|
Caffeine | 2 | 1985 | 699 | 0.020 |
Why?
|
Abdomen | 1 | 1996 | 1107 | 0.020 |
Why?
|
Respiration | 2 | 1986 | 1645 | 0.020 |
Why?
|
Postoperative Period | 1 | 1995 | 1839 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 1981 | 11690 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1998 | 6365 | 0.020 |
Why?
|
USSR | 1 | 1988 | 21 | 0.020 |
Why?
|
Hydrocarbons, Halogenated | 1 | 1988 | 20 | 0.020 |
Why?
|
Veratridine | 1 | 2008 | 24 | 0.020 |
Why?
|
Urethane | 1 | 1988 | 40 | 0.020 |
Why?
|
Risk Assessment | 1 | 2010 | 23320 | 0.020 |
Why?
|
Liver | 1 | 1984 | 7470 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1989 | 637 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2003 | 14554 | 0.020 |
Why?
|
Flumazenil | 1 | 1987 | 85 | 0.020 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 1990 | 161 | 0.020 |
Why?
|
Brain | 5 | 1997 | 26343 | 0.020 |
Why?
|
Bandages | 1 | 1989 | 267 | 0.020 |
Why?
|
Administration, Topical | 1 | 1989 | 688 | 0.020 |
Why?
|
Mechanoreceptors | 1 | 1987 | 186 | 0.020 |
Why?
|
Neurologic Examination | 1 | 1989 | 931 | 0.020 |
Why?
|
Pancuronium | 1 | 1984 | 45 | 0.020 |
Why?
|
Aged | 6 | 1996 | 162944 | 0.020 |
Why?
|
Constriction | 1 | 1984 | 181 | 0.020 |
Why?
|
Atmosphere Exposure Chambers | 1 | 1984 | 50 | 0.020 |
Why?
|
Microcomputers | 1 | 1985 | 147 | 0.020 |
Why?
|
Propanolamines | 1 | 1985 | 167 | 0.020 |
Why?
|
Cross Circulation | 1 | 1983 | 11 | 0.020 |
Why?
|
Volatilization | 1 | 1983 | 82 | 0.010 |
Why?
|
Pyrrolidines | 1 | 1986 | 342 | 0.010 |
Why?
|
Fluorometry | 1 | 1983 | 106 | 0.010 |
Why?
|
Lethal Dose 50 | 1 | 1983 | 77 | 0.010 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1989 | 700 | 0.010 |
Why?
|
Nitrous Oxide | 1 | 1984 | 177 | 0.010 |
Why?
|
Electric Stimulation | 2 | 1985 | 1770 | 0.010 |
Why?
|
Sodium | 1 | 2008 | 1627 | 0.010 |
Why?
|
Computers | 1 | 1985 | 611 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 1994 | 1873 | 0.010 |
Why?
|
Mitochondria, Heart | 1 | 1983 | 247 | 0.010 |
Why?
|
Europe | 1 | 1988 | 3339 | 0.010 |
Why?
|
Oxygen | 1 | 1993 | 4169 | 0.010 |
Why?
|
Fluorescence | 1 | 1983 | 751 | 0.010 |
Why?
|
Depression, Chemical | 3 | 1984 | 191 | 0.010 |
Why?
|
Vasopressins | 1 | 1982 | 370 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1985 | 1239 | 0.010 |
Why?
|
Intensive Care Units | 1 | 1991 | 3679 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1993 | 5705 | 0.010 |
Why?
|
Skin Physiological Phenomena | 1 | 1997 | 180 | 0.010 |
Why?
|
Mice | 1 | 2003 | 81045 | 0.010 |
Why?
|
Chronic Disease | 1 | 1991 | 9144 | 0.010 |
Why?
|
Acute Disease | 1 | 2006 | 7141 | 0.010 |
Why?
|
Child | 2 | 1993 | 77478 | 0.010 |
Why?
|
Muscimol | 1 | 1993 | 69 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1980 | 1869 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 19223 | 0.010 |
Why?
|
Radioisotopes | 1 | 1993 | 499 | 0.010 |
Why?
|
Blood Pressure | 3 | 1983 | 8541 | 0.010 |
Why?
|
Electrocardiography | 2 | 1986 | 6440 | 0.010 |
Why?
|
Chlorides | 1 | 1993 | 667 | 0.010 |
Why?
|
Prospective Studies | 1 | 1993 | 53187 | 0.000 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 1986 | 24 | 0.000 |
Why?
|
Receptors, Opioid, kappa | 1 | 1986 | 144 | 0.000 |
Why?
|
Ulnar Nerve | 1 | 1985 | 109 | 0.000 |
Why?
|
Mathematics | 1 | 1985 | 727 | 0.000 |
Why?
|
Hypotension, Controlled | 1 | 1982 | 15 | 0.000 |
Why?
|
Biotransformation | 1 | 1982 | 168 | 0.000 |
Why?
|
Evaluation Studies as Topic | 1 | 1985 | 1676 | 0.000 |
Why?
|
Verapamil | 1 | 1982 | 244 | 0.000 |
Why?
|
Electromyography | 1 | 1985 | 1391 | 0.000 |
Why?
|
Vasodilator Agents | 1 | 1982 | 976 | 0.000 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1983 | 1504 | 0.000 |
Why?
|
Ischemic Attack, Transient | 1 | 1982 | 934 | 0.000 |
Why?
|
Equipment Design | 1 | 1985 | 3582 | 0.000 |
Why?
|
Kinetics | 1 | 1982 | 6474 | 0.000 |
Why?
|
Risk | 1 | 1986 | 9679 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 1 | 1982 | 2267 | 0.000 |
Why?
|
Heart | 1 | 1982 | 4462 | 0.000 |
Why?
|
Hypertension | 1 | 1982 | 8455 | 0.000 |
Why?
|
Concepts
(332)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_